Has there been considered within it of some of those recommendations that have been provided by patient groups?
Monsieur Lemire just spoke to a number of those requests—changing the basket of countries, particularly taking out the U.S. and Switzerland, which I believe were the two that were creating a challenge; trying to find a way to implement the regulations over a longer period; and then trying to find a way to actually have true consultations between PMPRB and the patient groups.